CareDx Q2 2024 Adj. EPS $0.25 Beats $(0.14) Estimate, Sales $92.274M Beat $67.861M Estimate
Portfolio Pulse from Benzinga Newsdesk
CareDx (NASDAQ:CDNA) reported Q2 2024 earnings of $0.25 per share, significantly beating the analyst estimate of $(0.14). The company also reported sales of $92.274 million, surpassing the $67.861 million estimate. This represents a substantial improvement from the same period last year.
July 31, 2024 | 8:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CareDx reported Q2 2024 earnings of $0.25 per share, beating the $(0.14) estimate. Sales of $92.274 million also exceeded the $67.861 million estimate. This marks a significant improvement from the same period last year.
The significant beat on both EPS and sales estimates, along with substantial year-over-year improvements, is likely to positively impact CareDx's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100